- Mithra grants license to Chemical Dampe for commercialization of its vaginal contraceptive ring in Venezuela
- Strengthening of the commercial presence in Latin and South America
- Myring™ licenses granted to industry leaders in 36 countries, including the world’s three largest markets
Liege, Belgium, 10 November 2020 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it has entered into a license and supply agreement (LSA) with Chemical Dampe for the commercialization of its hormonal contraceptive ring Myring™ in Venezuela. Based in Venezuela, Chemical Dampe builds alliances for the health of Venezuelans focused on women’s health with advanced technology and high quality products, made inside and outside its borders.